compound 27 [PMID: 22142545]   

GtoPdb Ligand ID: 8757

Synonyms: SCH-1518291
Compound class: Synthetic organic
Comment: Compound 27 was developed in a SAR study to identify PDE10 inhibitors as potential schizophrenia pharmaceuticals [1]. This was the lead compound selected for further in vivo studies.
2D Structure
Click here for structure editor
Physico-chemical Properties
Hydrogen bond acceptors 4
Hydrogen bond donors 1
Rotatable bonds 3
Topological polar surface area 63.27
Molecular weight 340.19
XLogP 2.74
No. Lipinski's rules broken 0
SMILES / InChI / InChIKey
Canonical SMILES COc1cc(C)c2c(c1)c(CN1CCOCCC1)c1c(n2)n[nH]c1C
Isomeric SMILES COc1cc(C)c2c(c1)c(CN1CCOCCC1)c1c(n2)n[nH]c1C
InChI InChI=1S/C19H24N4O2/c1-12-9-14(24-3)10-15-16(11-23-5-4-7-25-8-6-23)17-13(2)21-22-19(17)20-18(12)15/h9-10H,4-8,11H2,1-3H3,(H,20,21,22)
InChI Key IPHACPSYWWYGQN-UHFFFAOYSA-N
Bioactivity Comments
Compound 27 is orally active and efficacious in the anti-hyperactivity MK-801 rat model [1].
Selectivity at enzymes
Key to terms and symbols Click column headers to sort
Target Sp. Type Action Value Parameter Concentration range (M) Reference
phosphodiesterase 10A Hs Inhibitor Inhibition 8.3 pKi - 1
pKi 8.3 (Ki 5x10-9 M) [1]